Top Markets
#1 Ontology Gas Ontology Gas +45.07%
#2 Anvil Anvil +19.32%
#3 ETHGas ETHGas +19.07%
#4 Status Status +18.81%
#5 The Black Bull The Black Bull +17.02%
#6 Geodnet Geodnet +16.47%
#7 Fake World Assets Fake World Assets +13.85%
#8 Derive Derive +10.68%
#9 Ontology Ontology +9.78%
#10 Gas Gas +9.27%
Coin of the day
Ontology Gas Ontology Gas
Paramètres
Langue
FRANçAIS
Devise
USD
Thème
ATyr Pharma, Inc. ATyr Pharma, Inc.

ATyr Pharma, Inc.

ATYR
Classement en actions #25451
aTyr Pharma, Inc., a biopharmaceutical firm established in San Diego,... aTyr Pharma, Inc., a biopharmaceutical firm established in San Diego, California, in 2005, is dedicated to the discovery and advancement of therapeutic solutions. Operating within the United States, the company's research focuses on pioneering novel immunological pathways to address various medical conditions. Its primary investigational drug, efzofitimod, functions as a selective modulator of NRP2. This compound is currently undergoing a Phase III clinical trial for pulmonary sarcoidosis. Additionally, efzofitimod is being evaluated in a Phase 1b/2a clinical study for the treatment of other interstitial lung diseases (ILDs), including conditions such as chronic hypersensitivity pneumonitis and ILDs linked to connective tissue diseases. Beyond its lead candidate, aTyr Pharma's pipeline features ATYR0101, a fusion protein derived from a domain of aspartyl-tRNA synthetase, which is in preclinical stages of development for combating fibrosis. The company is also progressing with ATYR0750, a domain sourced from alanyl-tRNA synthetase, intended for the management of liver disorders. Furthermore, aTyr Pharma has entered into a strategic collaboration and licensing agreement with Kyorin Pharmaceutical Co., Ltd. This partnership is focused on the development and commercialization of efzofitimod for interstitial lung diseases specifically within the Japanese market.
Prix de l'action
$0.5049
Dernière synchronisation: 2026-08-20
Capitalisation boursière
$49.51M
Changement (1 jour)
-5.24%
Changement (1 an)
-89.80%
Pays
US
Échange ATyr Pharma, Inc. (ATYR)

Catégorie

Healthcare
Le prix ATYR avec la capitalisation boursière de B
ATyr Pharma, Inc. ATyr Pharma, Inc.
ATYR
$0.5049
Capitalisation boursière de ATyr Pharma, Inc.(ATYR)
Capitalisation boursière: $49.51M
En August 2026, ATyr Pharma, Inc. a une capitalisation boursière de $49.51M. Cela fait de ATyr Pharma, Inc. la 25451st entreprise la plus valorisée au monde selon nos données. La capitalisation boursière, souvent appelée market cap, correspond à la valeur totale des actions en circulation d’une entreprise cotée en bourse, et est couramment utilisée pour évaluer sa valeur.
Historique de la capitalisation boursière de ATyr Pharma, Inc. du 2024 au 2026
ATYR par rapport au top 5 des plus populaires stocks
Prix pour ATYR L’actif B La capitalisation boursière de B Résultats
ATyr Pharma, Inc. ATyr Pharma, Inc.
$53,612.85 $49.51M
NVIDIA Corporation NVIDIA Corporation
NVDA
$5.257T +10,618,409.54%
ATyr Pharma, Inc. ATyr Pharma, Inc.
$46,900.10 $49.51M
Apple Inc. Apple Inc.
AAPL
$4.599T +9,288,888.08%
ATyr Pharma, Inc. ATyr Pharma, Inc.
$41,881.66 $49.51M
Alphabet Inc. Alphabet Inc.
GOOG
$4.107T +8,294,939.90%
ATyr Pharma, Inc. ATyr Pharma, Inc.
$36,483.20 $49.51M
Microsoft Corporation Microsoft Corporation
MSFT
$3.577T +7,225,726.99%
ATyr Pharma, Inc. ATyr Pharma, Inc.
$28,630.76 $49.51M
Amazon.com, Inc. Amazon.com, Inc.
AMZN
$2.807T +5,670,480.34%